Management of First-Episode Psychosis and Schizophrenia
Assessment and Evaluation of Suspected Psychosis
First-episode Psychosis
Pharmacologic Interventions for Psychosis
Pharmacologic Interventions for Treatment of Side Effects
Non-pharmacologic Interventions
- Cognitive behavioral therapy or cognitive behavioral therapy for psychosis, ·
- Acceptance and mindfulness-based therapies, ·
- Metacognitive therapy, or
- Positive psychology interventions.
Management of Co-occurring Conditions
Algorithms
Module A: Primary Care Evaluation and Management of Suspected Psychosis or Possible Schizophrenia
Module B: Evaluation and Management of First-Episode Psychosis and Schizophrenia by Mental Health Providers
Module C: Pharmacotherapy for Treatment of First-Episode Psychosis and Schizophrenia
Module C Part 2 - Pharmacotherapy for Treatment of First-Episode Psychosis and Schizophrenia
Recommendation Grading
Disclaimer
Overview
Title
Management of First-Episode Psychosis and Schizophrenia (SCZ)
Authoring Organization
Veterans Health Administration / Department of Defense
Publication Month/Year
May 10, 2023
Last Updated Month/Year
April 1, 2024
Supplemental Implementation Tools
Document Type
Guideline
Country of Publication
US
Target Patient Population
Adults with schizophrenia, schizophrenia spectrum disorders, schizoaffective disorder, schizophreniform disorder, or FEP being treated in any setting
Target Provider Population
VA and DoD providers to care for patients with schizophrenia, including primary care providers (PCP), mental health providers, and others involved in the health care team
Inclusion Criteria
Male, Female, Adult, Older adult
Health Care Settings
Ambulatory, Outpatient
Intended Users
Nurse, nurse practitioner, physician, physician assistant, psychologist
Scope
Counseling, Assessment and screening, Treatment, Management
Diseases/Conditions (MeSH)
D012559 - Schizophrenia, D011609 - Psychosine
Keywords
psychosis, schizophrenia, veterans, VA
Source Citation
VA/DoD Clinical Practice Guideline. (2023). Management of First-Episode Psychosis and Schizophrenia Work Group. Washington, DC: U.S. Government Printing Office.